ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel, for the detection of C. trachomatis, N. gonorrhoeae and M. genitalium
Puteaux, France, 9th June 2017 – ELITechGroup Molecular Diagnostics announces the CE-IVD marking of the STI ELITe MGB® Panel: a multiplex assay for the detection of… See Details
ELITechGroup Molecular Diagnostics announced the CE-IVD marking of the Coagulation ELITe MGB® Kit, a multiplex assay for the detection of Factor V, Factor II, and MTHFR genetic variants
Puteaux, France, 27th January 2017 – ELITechGroup Molecular Diagnostics announced today the CE-IVD marking of the Coagulation ELITe MGB® Kit, a high-performance, multiplex assay for… See Details
ELITechGroup receives FDA Emergency Use Authorization for Zika ELITe MGB® Kit U.S. performedusing the ELITe InGenius™ instrument
ELITechGroup announced today that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the Zika ELITe MGB® Kit U.S…. See Details
ELITechGroup Announces Agreement with Abbott to Expand Distribution Channels
Puteaux, France November 9th, 2016 – ELITechGroup today announced a U.S. distribution agreement, with Abbott’s Molecular business, for molecular diagnostic reagents. The reagents target a… See Details
ELITechGroup Molecular Diagnostics announce the CE-IVD marking of the CRE ELITe MGB® Kit, for the detection of the Carbapenem Resistance genes of Enterobacteriaceae
Puteaux, France November 8th, 2016 – ELITechGroup Molecular Diagnostics announce today the CE-IVD marking of the CRE ELITe MGB® kit, a high-performance, qualitative, multiplex assay… See Details
NEW – Press release – Rapid Detection of Resistance to Polymyxins
Signes, France – October 17th, 2016 – Among the most clinically significant multidrug-resistant bacteria are carbapenemase-producing Enterobacteriaceae. Because these bacteria usually remain susceptible to polymyxins,… See Details